We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+11.07%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$48.8B
AUM Growth
+$7.31B
Cap. Flow
+$2.97B
Cap. Flow %
6.1%
Top 10 Hldgs %
18.45%
Holding
760
New
71
Increased
309
Reduced
252
Closed
53

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$305M
2
CVS icon
CVS Health
CVS
+$190M
3
NVS icon
Novartis
NVS
+$175M
4
AVGO icon
Broadcom
AVGO
+$154M
5
WDC icon
Western Digital
WDC
+$144M

Sector Composition

Rank Sector Weight
1 Financials 24.38%
2 Healthcare 15.25%
3 Technology 13.09%
4 Industrials 10.62%
5 Energy 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$650B
$1.36B 2.78%
13,393,086
+3,301,127
+33% +$305M
JPM icon
2
JPMorgan Chase
JPM
$930B
$1.11B 2.28%
19,047,821
+589,602
+3% +$32.3M
WFC icon
3
Wells Fargo
WFC
$261B
$984M 2.02%
21,677,235
+1,382,244
+7% +$59.7M
C icon
4
Citigroup
C
$221B
$936M 1.92%
17,952,458
+1,004,909
+6% +$50.9M
PFE icon
5
Pfizer
PFE
$143B
$893M 1.83%
30,718,614
+1,558,569
+5% +$45.4M
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.06T
$821M 1.68%
6,928,147
+616,283
+10% +$71.3M
JNJ icon
7
Johnson & Johnson
JNJ
$624B
$766M 1.57%
8,360,600
+372,622
+5% +$34.3M
OXY icon
8
Occidental Petroleum
OXY
$57.3B
$739M 1.52%
8,113,419
-722,246
-8% -$65.9M
COF icon
9
Capital One
COF
$123B
$738M 1.51%
9,638,153
+995,528
+12% +$70.9M
LEA icon
10
Lear
LEA
$7.14B
$652M 1.34%
8,050,824
+611,756
+8% +$47.9M
CSCO icon
11
Cisco
CSCO
$444B
$623M 1.28%
27,752,915
+1,329,314
+5% +$29.4M
MCK icon
12
McKesson
MCK
$96.5B
$605M 1.24%
3,748,448
-865,253
-19% -$133M
AMGN icon
13
Amgen
AMGN
$201B
$585M 1.2%
5,125,667
+13,425
+0.3% +$1.53M
SNY icon
14
Sanofi
SNY
$104B
$566M 1.16%
10,545,012
+1,622,742
+18% +$83.7M
CVS icon
15
CVS Health
CVS
$136B
$558M 1.14%
7,800,622
+2,963,869
+61% +$190M
PSX icon
16
Phillips 66
PSX
$83B
$540M 1.11%
7,006,929
+1,951,993
+39% +$130M
DOV icon
17
Dover
DOV
$26.6B
$515M 1.06%
7,956,865
+524,845
+7% +$32.1M
FITB
18
Fifth Third Bancorp
FITB
$51.8B
$494M 1.01%
23,478,443
+2,367,118
+11% +$46.4M
MSFT icon
19
Microsoft
MSFT
$2.83T
$492M 1.01%
13,154,153
+860,135
+7% +$31.2M
CMCSA icon
20
Comcast
CMCSA
$78.3B
$483M 0.99%
18,606,974
+1,776,888
+11% +$42.8M
TFC icon
21
Truist Financial
TFC
$62.5B
$482M 0.99%
12,902,593
+1,040,417
+9% +$36M
ESRX
22
DELISTED
Express Scripts Holding Company
ESRX
$457M 0.94%
6,501,229
+1,021,308
+19% +$66.7M
OCR
23
DELISTED
OMNICARE INC
OCR
$456M 0.94%
7,558,364
+1,093,430
+17% +$62.6M
BAC icon
24
Bank of America
BAC
$430B
$438M 0.9%
28,123,713
+2,796,083
+11% +$41.5M
PH icon
25
Parker-Hannifin
PH
$124B
$434M 0.89%
3,371,035
+286,339
+9% +$33.3M

Similar funds

Boston Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Boston Partners held 760 positions worth $48.8B, up 18% from $41.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners deployed $2.97B of net new capital in Q4 2013, opening 71 new positions and adding to 309 existing holdings. Its largest new stake was Novartis: 2,524,138 shares worth $182M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Halliburton, an estimated $260M trimmed.

  • Boston Partners's largest Q4 2013 buy was Novartis: 2,524,138 shares worth $182M.
  • Boston Partners added most to ExxonMobil in Q4 2013, an estimated $305M increase.
  • Boston Partners's biggest Q4 2013 reduction was Halliburton, cutting an estimated $260M.
  • Boston Partners fully exited NVIDIA in Q4 2013, selling an estimated $131M.
  • Boston Partners's ten largest holdings make up 18% of its $48.8B portfolio in Q4 2013.
  • Boston Partners opened 71 new positions and closed 53 in Q4 2013.
  • Boston Partners's portfolio value rose 18% quarter-over-quarter to $48.8B.

Based on Boston Partners's 13F filing for Q4 2013, filed 6 Feb 2014.